Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...

Eli Lilly and Company has announced plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Puerto Rico.

Debiopharm has entered a strategic research collaboration with NetTargets to design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-gen ADCs.

Cryoport Systems was actively involved in the development of the ISO 21973 standard through its participation in the Standards Coordinating Body working group. The standard, intro ...

Agreement expands Piramal’s payload-linker platform and bioconjugate abilities.

New services enable early assessment of compound safety and neurotoxic risk in drug discovery.

Mencfeld, CEO of Rezon Bio, was awarded the Woman of the Year title at the 2025 CPHI Pharma Awards at CPHI Frankfurt.

Apeloa Pharmaceutical, a global provider of technology-driven pharmaceutical manufacturing solutions, has passed its 20th U.S. FDA inspection.

With over twenty-five years of experience, Alen will drive Aboleris' strategic partnerships, financing activities, and corporate growth initiatives.

The Pistoia Alliance, a global, not-for-profit alliance, is launching Phase 3 of its Chemistry, Manufacturing and Controls (CMC) Process Ontology project.

Senior Director of Business Development shares insight on industry trends and outsourcing.

Will transfer commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities.